|Dr. William F. Feehery Ph.D.||CEO & Director||1.35M||N/A||1971|
|Mr. Leif E. Pedersen||President & Chief Commercial Officer||625.53k||N/A||1965|
|Dr. Robert P. Aspbury Ph.D.||President of Certara Scientific Software||518.09k||N/A||1972|
|Dr. Patrick F. Smith Pharm.D.||President of Drug Development Solutions||621.58k||N/A||1971|
|Mr. John E. Gallagher III||Chief Financial Officer||N/A||N/A||1973|
|Mr. Max Kanevsky||Chief Technology Officer||N/A||N/A||N/A|
|Prof. Amin Rostami PharmD, Ph.D., FCP||Chief Scientific Officer||N/A||N/A||N/A|
|Mr. Richard M. Traynor||Senior VP, General Counsel & Secretary||N/A||N/A||1972|
|Mr. Ron DiSantis||Senior Vice President of Corporate Development||N/A||N/A||N/A|
|Ms. Sheila Rocchio MBA||Chief Marketing Officer||N/A||N/A||N/A|
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, the Netherlands, the Philippines, Poland, Portugal, Spain, Switzerland, and the United Kingdom. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Certara, Inc.’s ISS Governance QualityScore as of November 1, 2023 is 5. The pillar scores are Audit: 7; Board: 5; Shareholder Rights: 8; Compensation: 3.